Abstract | Cardiovascular disease (CVD) is the most-prevalent noncommunicable disease and leading cause of death globally. Over 80% of deaths from CVD occur in low-income and middle-income countries (LMICs). To limit the socioeconomic impact of CVD, a comprehensive approach to health care is needed. Cardiac rehabilitation delivers a cost-effective and structured exercise, education, and risk reduction programme, which can reduce mortality by up to 25% in addition to improving a patient's functional capacity and lowering rehospitalization rates. Despite these benefits and recommendations in clinical practice guidelines, cardiac rehabilitation programmes are grossly under-used compared with revascularization or medical therapy for patients with CVD. Worldwide, only 38.8% of countries have cardiac rehabilitation programmes. Specifically, 68.0% of high-income and 23% of LMICs (8.3% for low-income and 28.2% for middle-income countries) offer cardiac rehabilitation programmes to patients with CVD. Cardiac rehabilitation density estimates range from one programme per 0.1 to 6.4 million inhabitants. Multilevel strategies to augment cardiac rehabilitation capacity and availability at national and international levels, such as supportive public health policies, systematic referral strategies, and alternative models of delivery are needed.
Introduction
Cardiovascular disease (CVD) is the most prevalent noncommunicable disease and the leading cause of death globally. 1 The burden of CVD is growing, particularly in low-income and middle-income countries (LMICs); >80% of deaths related to CVD occur in LMICs. [1] [2] [3] By 2030, 23 million people per year are predicted to die from CVD. 4 According to the World Economic Forum, in 2010, 62.5 million new cases of CVD were reported, of which 24.2 million were attributed to ischaemic heart disease ( Table 1) . 4 By 2030, this number is expected to grow to 84 million individuals diagnosed with CVD, of whom up to 32.3 million will have ischaemic heart disease. 4 Patients with established CVD have a high risk of adverse cardiovascular events, such as fatal and nonfatal myocardial infarction. 5 Consequently, CVD is also the leading cause of disability, 6 accounting for 10% of d isability-adjusted life years (DALYs; Box 1 7 ) lost worldwide, 10% of DALYs lost in LMICs, and 18% of DALYs lost in high-income countries. 8 Worldwide, 47 million DALYs were lost in 1990 due to coronary heart disease (CHD), a figure that is expected to rise to 82 million DALYs by 2020. 8 In 2010, an estimated 111.7 million individuals-that is 1.62% of the total world's population-had angina due to ischaemic heart disease, as reported in the Global Burden of Disease Study. 9 In response to the emerging economic and social burden of noncommunicable diseases, the WHO has set a global target for reduction of "premature deaths from noncommunicable diseases by 25% by 2025". 10 All 194 WHO Member States endorsed this target during the 65 th World Health Assembly in 2012. 10 In the Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020, the WHO underlines the need for rehabilitation, including cardiac rehabilitation, to combat the burden of CVD. 11 Cardiac rehabilitation is a strategy to reduce CVD risk factors, such as obesity and physical inactivity, restore heart function, and limit health deterioration owing to CVD, as well as expedite hospital discharge, and improve patient quality of life. 11 Given the current and expected increases in rates of CVD, cardiac rehabilitation capacity will need to be high to meet such demand.
In this Review we describe the availability of cardiac rehabilitation both in high-income countries and in LMICs, and highlight the varying density of this treatment in these countries. We consider rates of physician referral to cardiac rehabilitation and the availability of cardiac rehabilitation compared with other evidencebased prevention therapies. The reasons for low availability of cardiac rehabilitation and approaches to increase provision at the health-care policy and programme level are also explored. Cardiac rehabilitation is a secondary and tertiary prevention strategy for future CVD events and we focus on this treatment as delivered in the outpatient setting.
underlying cause of the disease, as well as to provide the best possible physical, mental, and social conditions, so that the patients may, by their own efforts, preserve or resume when lost, as normal a place as possible in the community". 13 National and international associations, such as the American Association of Cardiovascular and Pulmonary Rehabilitation and the European Association of Cardiovascular Prevention and Rehabilitation have established the core components of cardiac rehabilitation. 14, 15 These include an initial assessment of patients to identify cardiovascular risk factors and comorbidities, physical activity training, nutritional advice, management of risk factors (for example, dyslipidaemia, hypertension, obesity, diabetes mellitus, and smoking), Key points ■ Cardiac rehabilitation services are poorly implemented worldwide, with only 38.8% of countries having such a programme ■ Cardiac rehabilitation services are available in only 23% of low-income and middle-income countries, which have the greatest cardiovascular disease burden and highest cardiovascular mortality ■ Cardiac rehabilitation density is greatest in the USA where one programme per 102,000 inhabitants is provided; middle-income countries have approximately one programme per 1-6 million individuals ■ Worldwide <50% of eligible patients are referred to cardiac rehabilitation programmes ■ Cardiac rehabilitation services are less-often implemented, despite costing much less to implement, than other evidence-based secondary prevention therapies ■ More research is required to evaluate effectiveness of affordable and feasible cardiac rehabilitation models that utilize new technologies, in both high-income and low-to-middle-income countries psychosocial interventions, and counselling. 14 These components promote and maintain healthy behaviour, active lifestyles, and can improve quality of life and reduce disability. 14 Robust evidence demonstrates that participation in a cardiac rehabilitation programme reduces mortality by up to 25% over an average of 5 years when compared with usual care, such as medical therapy alone. [16] [17] [18] [19] [20] [21] The only risks of cardiac rehabilitation are potential adverse cardiac events while exercising, such as arrhythmia. However, rates of these adverse events are low in cardiac rehabilitation programmes. For example, in a French study, the rate of severe cardiac events was one per ~50,000 patienthours of exercise training, with a cardiac arrest rate of 1.3 per million patient-hours of exercise. 22 According to clinical practice guidelines, cardiac rehabil itation is recommended for patients with a primary diagnosis of myocardial infarction, angina, or heart failure, and who have undergone CABG surgery, percutaneous coronary intervention (PCI), or a heart or lung transplant.
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Global availability
We identified all those countries recognized by the World Bank with an active cardiac rehabilitation programme and classified them according to income (Box 1; Figure 1 ). Cardiac rehabilitation availability in many high-income countries has been described in national and regional surveys, such as the CARINEX Survey, 26 and the European Cardiac Rehabilitation Inventory Survey. 27 Of the 75 high-income countries defined by the World Bank, cardiac rehabilitation services are available in only 51 (68.0%; Figure 1 ).
26-63
The most-comprehensive data on the availability of cardiac rehabilitation in middle-income countries were published in two regional surveys: a survey of Latin America and Caribbean with 14 participating countries, 64 and a South American survey of nine countries. 36 The authors of a 2013 review reported that cardiac rehabilitation services are available in only 22.1% of LMICs. 65 Cardiac rehabilitation services exist in 29 (28.2%) of the 103 World Bank defined middle-income countries ( Figure 1) . 36, 37, [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] Of the 36 low-income countries, cardiac rehabilitation services were available in only three (8.3%)-Afghanistan, 79 Bangladesh, 80 and Kenya. 81 Overall, cardiac rehabilitation is available in only 38.8% countries worldwide. More specifically and of concern, cardiac rehabilitation services are available in only 23% of the LMICs, where >80% of CVD deaths occur, 82 underlining the insufficient supply of such interventions in c ountries with the greatest cardiovascular burden.
Density
The number of cardiac rehabilitation programmes per inhabitant (which we refer to as cardiac rehabilitation density), is a crude estimate of the number of patients who might have access to cardiac rehabilitation in each country. Although the number of patients who are indicated for cardiac rehabilitation per programme might be more informative to assess provision of this treatment; 36, 45 unfortunately, data on CVD prevalence are not available for many countries. Moreover, using the number of patients indicated for a programme is limited by the variation in the number of patients treated across cardiac rehabilitation programmes, which can range from 75 to 232 patients per programme according to one study conducted in the USA. 83 However, no accepted density threshold that indicates sufficient cardiac rehabilitation capacity has been established. A position statement recommends a benchmark of 70% enrolment for cardiac rehabilitation; 33 however, the translation of this recommendation into a density value has yet to be undertaken. In line with previous research, 36 the density of cardiac rehabilitation is presented and for the first time, c ompared across regions of the world (Table 2) .
High-income countries
Based on national and regional surveys in high-income countries, cardiac rehabilitation density ranges from one programme per 100,000 to one programme per 300,000 inhabitants (Table 2) . 36, 45, 84 An exception is Chile, which was only classified as a high-income country in 2013 and, consequently, has a lower density of programmes consistent with the density found in middle-income countries. 85 In the USA, which has the highest cardiac rehabilitation programme density worldwide, one programme per 102,000 inhabitants was available in 2003, with a range of one programme per 23,000-261,000 inhabi tants depending on region (the highest density was in Nebraska and the lowest in California). 84 
LMICs
In middle-income countries, cardiac rehabilitation density is lower than in high-income countries, ranging from 0.9 to 6.4 million inhabitants per programme (Table 2) . 36 Cardiac rehabilitation density in the USA was almost 23-fold greater than that reported in South America, which has an estimated 2.3 million inhabitants per programme. 36 Furthermore, although cardiac rehabilitation density was one programme per <500,000 inhabitants in high-income countries, 36, 45, 84 in middle-income countries, the density was one programme per 1-6 million inhabitants. 36 The density of cardiac rehabilitation programmes in low-income countries has not been reported. Our extensive search identified only one programme per country in the three low-income countries where cardiac rehabilitation was found to exist-Afghanistan, 79, 86 Bangladesh, 80, 86 and Kenya. 81, 86 Patient access
Physician referral
Patient referral to a cardiac rehabilitation programme by a physician is a prerequisite step for participation in most countries. In high-income countries, low or no physician referral to cardiac rehabilitation is a key barrier to patients enrolling in a programme, according to several studies. 33, 36, [87] [88] [89] [90] [91] For example, in some studies, 71% of eligible patients were not referred and were, therefore, unable to access to cardiac rehabilitation (Table 3 ). In the EUROASPIRE III Survey, 50 conducted in 22 European countries (19 classed as high-income), only 44.8% of 8,845 patients eligible for cardiac rehabilitation were advised by physicians or other health-care professionals to attend a programme. However, whether this advice was a formal referral or verbal recommendation was not stated in the study. Therefore, the true rate of referral from completion and transmission to the cardiac rehabili tation programme is not known and the rate is likely to be an overestimate.
In LMICs, physician referral to cardiac rehabilitation has been investigated in very few studies, and in these countries, where reported, referral rates are even lower than those in high-income countries. For example, in a survey undertaken in Iran, cardiologists reported that <15% of patients are referred. 92 In a review on cardiac rehabilitation in Brazil, low cardiac rehabilitation referral was reported as a barrier to enrolment. 67 In several m iddle-income countries of Europe, car diac rehabilitation 'advice' rates (that is, patients advised to seek a cardiac rehabilitation programme) in the EUROASPIRE III survey 50 were reported to range from 7.3% in Turkey to 57.0% in Hungary (Table 3) . Again, these percentages are likely to be overestimates of true referral rates.
Disparities in patient access
Variability in cardiac rehabilitation use has been documented in high-income countries. 12, 89, 90 For example, certain patient groups are less likely to be referred and, therefore, to participate in cardiac rehabilitation. 12, 89, 90 These groups include women, elderly patients, individuals from ethnic minorities, patients of low socio economic status, and those with comorbidities. 62, 89, 90, 93 These patients often have a greater need for cardiac rehabilitation, as demonstrated by evidence of poorer outcomes and greater disease management complexity in these individuals than in other patients. However, patients at greatest need face multiple barriers to participation including low health literacy, lack of proficiency in the language in which cardiac rehabilitation is offered, or lack of transportation. In middle-income countries, women are under-represented compared with men, representing <30% of patients participating in cardiac rehabilitation programmes. 70, 73, 94, 95 In one study from Brazil, no women attended the cardiac rehabilitation programme. 96 Given that no evidence has been presented that these patient groups derive less clinical benefit from cardiac rehabilitation, efforts to ensure patient access is equal for all socioeconomic groups are needed.
Comparison with other interventions
The WHO states that "cardiac rehabilitation should be an integral component of the long-term, comprehensive care of cardiac patients". 97 However, in high-income countries, governments allocate more resources to acute CVD treatment than less expensive, long-term disease management strategies, such as cardiac rehabilitation (Box 2). 46, 64 In a national survey, only 6.5% of 1,059 surveyed hospitals in Japan were approved for reimbursement of cardiac rehabilitation services by the Japanese health insurance system. 46 Whereas, 61.8% and 58.8% of hospitals in Japan implement coronary angiography and PCI, respectively, following myocardial infarction. 46 Although acute revascularization strategies such as CABG surgery and PCI confer benefit for patients, cardiac rehabilitation is also considered a Class IA indication in clinical practice guidelines (that is the treatment is useful and effective). 25, 98 CABG surgery reduces mortality by 39% (OR 0.61, 95% CI 0.48-0.77) at 5-year follow-up 99 and PCI by 20% (OR 0.80, 95% CI 0.64-0.99) at an average of 4-year follow-up. 100 In a review of 34 different trials, cardiac rehabilitation had comparable mortality reductions to the invasive procedures of 26%, over 3 months to 5-year follow-up (OR 0.74, 95% CI 0.58-0.95). 101 Moreover, in a study conducted in the USA, out of the 10 known effective treatments for myocardial infarction and their degree of implementation, cardiac rehabilitation ranked second, after revascularization, as the treatment which would prevent or postpone the greatest number of deaths. 102 In the same study, cardiac rehabilitation pro vision was estimated to prevent or postpone the greatest number of deaths in patients with unstable angina and heart failure compared with other treatments. 
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REVIEWS
Health-care systems in middle-income countries are starting to provide expensive revascularization procedures. 64 Although such procedures are appropriate given the epidemic of CVD, resources are still very limited and where possible alternatives might be more suitable than revascularization in these countries. 64 As in high-income countries, the cost of cardiac rehabilitation provision in LMICs is likely to be much less than that of acute revascularization, although no specific data are currently available. In patients at low-risk of a cardiovascular event (for example, those with a Thrombolysis In Myocardial Infarction risk score of 1 or 2), revascularization at the time of acute care admission is unlikely to change clinical outcome 103 and, therefore, is not only costly but futile. Mortality reductions can be achieved with noninvasive medical therapy and cardiac rehabilitation in low-risk patients. 99, 104 If revascularization was discontinued in low-risk individuals, and the associated financial costs diverted to cardiac rehabilitation, resources for such programmes would greatly increase. Cardiac rehabilitation should, therefore, be developed in combination with the building of operating theatres and cardiac catheterization facilities. However, a survey of centres offering cardiac catheterization in 13 countries in Latin America revealed that only 56% had cardiac rehabilitation programmes. 64 Cardiac rehabilitation is also used less often than other guideline-recommended secondary prevention therapies, such as medical therapy. 105 For example, in a study on implementation of the AHA 'Get with the Guidelines' programme, multiple hospitals reported that they were able to achieve high rates of aspirin (94%), β-blocker (92.5%), and angiotensin-converting enzyme inhibitor (84.8%) use. 106 These figures are in stark contrast to the rates of inpatient cardiac rehabilitation referral (56%) using the same guidelines programme. 88 For outpatient care, data from the ACC Practice Innovation and Clinical Excellence (PINNACLE) programme similarly reveal greater provision of evidence-based therapies, such as drug therapies, smoking cessation, and blood pressure and lipid measurement and control, than for cardiac rehabilitation. 103 In a sample of 8,132 patients with coronary artery disease, cardiac rehabilitation referral was only 18.1%. 103 Only screening for diabetes had a lower referral rate (13.3%) in this study. The most common practice recommendations implemented were blood pressure measurement (94.0%), smoking a ssessment (83.8%), and annual lipid assessment (74.3%). 103 LMICs have higher provision of noncardiac rehabilitation secondary prevention recommendations than cardiac rehabilitation. 37, 107 For instance, across 10 LMICs (Brazil, Egypt, India, Indonesia, Iran, Pakistan, Russian Federation, Sri Lanka, Tunisia, and Turkey), 81.2% of patients with CHD received aspirin, 48.1% β-blockers, 39.8% angiotensin-converting enzyme inhibitors, and 29.8% statins. 107 Unfortunately, the average rate of cardiac rehabilitation use in LMICs has yet to be reported.
Reasons for under-use
Much research has been conducted in high-income countries to identify reasons for under-use of cardiac rehabilitation despite its benefits. For example, the authors of one systematic review associated 253 different patient-related factors with the uptake of lifestyle change programmes, including cardiac rehabilitation. 108 The reasons can be characterized at three inter-related levels: patient, provider, and health-care system.
The most-commonly reported patient-related cardiac rehabilitation barriers included old age, low socio economic status, employment obligations and subsequent time conflicts, patient disinterest in attending a programme, and comorbidities. 12, 74, 87, 89, 90, [105] [106] [107] [108] [109] [110] [111] Despite the relative scarcity of studies on barriers to cardiac rehabilitation from middleincome countries, the barriers that have been reported are similar to those in high-income countries. 74, 89, 92, 96 In low-income countries, no studies on b arriers to cardiac r ehabilitation programmes were identified.
In high-income and middle-income countries, physicians have an important role in the use of cardiac rehabilitation. 12, 92, 110, 112 Inadequate physician knowledge about the benefits of cardiac rehabilitation, a lack of incentives to refer a patient, and low physician endorsement of programmes have been often described. 92, 110 Low physician referral rates might be compounded by a subjective assessment of a patient's ability (or inability) to participate, and a lack of implementation of systematic cardiac rehabilitation referral strategies at patient discharge. 34, 112, 113 Moreover, financial compensation for physicians to provide cardiac rehabilitation is either nonexistent or negli gible. For example, in Iran, cardiologists attributed a low physicians' fee among other factors for low referral rates. Furthermore, in Latin America, catheterization centre administrators and physician leaders suggest that financial constraints and low profitability are barriers to availability of cardiac rehabilitation. 64 The most-common explanation for lower availability of cardiac rehabilitation compared with expensive cardiac procedures in Latin America was that cardiac rehabilitation is not viewed as an investment priority for health-care institutions. 64 This lack of funding leads to low human resource capacity to deliver cardiac rehabilitation and, in turn, a lack of programmes to which physicians can refer their patients. Limited availability of programmes, financial constraints, distance, transportation problems, and a lack of insurance coverage are some of the most frequently-reported system-level barriers to cardiac rehabilitation access in high-income and middle-income countries. 12, 92, 96, 108, 110 The barriers to cardiac rehabilitation programmes have only been investigated in the middle-income countries of Brazil, Iran, and Pakistan. 74, 92, 96 In Iran, physicians perceive that low patient referral is due to limited knowledge about cardiac rehabilitation and its benefits, limited knowledge about methods of financial reimbursement, and a lack of insurance coverage. 92 In Brazil, distance, cost, lack of patient knowledge, and work and family responsibilities were all cited by physicians as barriers to cardiac rehabilitation participation. 96, 114 Similarly, employment conflicts and distance were reported by physicians as the main limits to participation in cardiac rehabilitation p rogrammes in Pakistan. 74 
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Increasing provision
In high-income countries, societies such as the AHA strongly advocate an increase in cardiac rehabilitation provision, 115 and these calls should also be emphasized in LMICs. Implementation of evidence-based care is highly dependent on policy-makers, health-care professionals, and patients. 116, 117 The Theoretical Domains Framework 116 integrates 33 theories of behaviour change into 12 domains including skills, professional role and identity, reinforcements, cognition, and environmental context and resources, to address complex implementation problems. 116 Although no study has yet reported on the effectiveness of the Theoretical Domains Framework in cardiac rehabilitation, these theories have been successfully applied in other areas of health care. 118 The Theoretical Domains Framework might be useful for developing interventions that overcome the gap in cardiac rehabilitation implementation, through its consideration of theory, evidence, and logistical barriers.
Strategies to improve rehabilitation service delivery worldwide have been described by the WHO. 119 These strategies include reforming health-care policies, increasing research, developing funding mechanisms to address barriers, increasing human resources in health care, expanding and decentralizing service delivery, and increasing the use and affordability of technology.
Policies to increase capacity
To address the inadequate availability of cardiac rehabilitation worldwide, co-ordinated efforts at national and international levels are required. 120 Surveys of cardiac rehabilitation programme directors in high-income and middle-income countries have confirmed the need for national policies to support provision and comprehensive reimbursement. 64, 121 Results from the European Cardiac Rehabilitation Inventory Survey 27 indicate that only 46% of the 28 participating countries had national legislation regarding cardiac rehabilitation, 57% had national professional guidelines, and 75% had government funding. 27 In a survey of Latin America and the Caribbean, lack of health insurance coverage for cardiac rehabilitation, and lack of regulatory health policies were highlighted among the reasons for poor implementation of cardiac rehabilitation by programme directors and physician leaders. 64 Although sufficient evidence exists to support the provision of cardiac rehabilitation in high-income countries, few randomized controlled trials of such treatments have been undertaken in LMICs. 68, 122, 123 However, improvements in clinical outcomes are expected in LMICs in response to cardiac rehabilitation programmes, given the low rates of screening and control of CVD risk factors. 124 With expanded, context-specific research evidence, government health ministries might then implement publichealth policies that acknowledge, promote, and prioritize resources to support cardiac rehabilitation. 64 In LMICs, a major discrepancy between the pro vision of expensive coronary interventions and inexpensive alternative therapies highlights the need for novel funding models to promote more cost-effective strategies such as cardiac rehabilitation in these resource-poor regions. 64 For instance, the British Association for Cardiovascular Prevention and Rehabilitation cardiac rehabilitation standards suggest that cardiac rehabilitation should be part of the "integrated cardiology service". 125 As cardiology services are developed in LMICs, cardiac rehabilitation should be a required service after a cardiovascular disease-related event or procedure. Such low-cost programmes might, therefore, reduce the need for repeat r evascularization and other downstream medical care utilization.
Expanding human resources and service delivery in health care, as recommended by the WHO, is likely to have a substantive impact in increasing cardiac rehabilitation supply. Cardiac rehabilitation should be incorporated into the training and education of future health-care providers, from community health-workers to physicians. The provision of core cardiac rehabilitation elements, such as self-management education for patients, could be allocated to nurses rather than physicians. Other approaches, such as increasing the hours of operation of existing programmes to enable an increased number of patients to attend, and the development of satellite sites based on well-established programmes could also greatly increase cardiac rehabilitation capacity.
Health-care systems
If physicians increase patient referral rates for cardiac rehabilitation, the pressure to expand provision in health-care systems will also increase. In a systematic review, three randomized controlled trials of interventions to increase patient uptake of cardiac rehabilitation were identified. 126 These studies were conducted in high-income countries, and all were successful in increasing patient participation in the programme. One trial was low-cost, which simply involved a motivational letter to patients. 127 The other two trials were more complex and human resourceintensive. For example, one involved liaison nurses who co-ordinated the transfer of care between hospital and general practice, and encouraged general practice nurses to prompt and guide structured follow-up. 128 In the other trial, the intervention included an in-hospital visit from a social worker and a motivational telephone call 4 weeks after hospital discharge. 129 The investigators of a further study, published in 2013, also detailed that the provision of a theory-based invitation letter aimed at changing patient behaviour improved attendance at cardiac rehabilitation. 130 These low-cost, simple methods should be adapted and tested in middle-income countries.
Systematic cardiac rehabilitation referral is a policy that demonstrably increases programme participation. 131 Several associations have endorsed cardiac rehabilitation referral as a care quality metric, 33 including the American Association of Cardiovascular and Pulmonary Rehabilitation, 132 the European Association for Cardiovascular Prevention and Rehabilitation, 15 and the Canadian Association of Cardiovascular Prevention and Rehabilitation. 133 The American Association of Cardiovascular and Pulmonary Rehabilitation is close to achieving 'pay-for-performance' for cardiac rehabilitation referral, a funding reform that represents a disruptive innovation to increase programme participation rates. 134 Pay-for-performance describes the use of financial rewards or penalties to encourage the provision of high-quality care. Hospitals or health-care providers are required to report on a core set of performance indicators. If a hospital fails to report, a financial penalty is initiated; financial rewards are given to hospitals for achievement of the measures. Along with other performance measures, such as prescription of statins, inpatient cardiac rehabilitation referral would be linked to payment or full r eimbursement for a patient's care. 134 Alternative models of delivery Owing to the challenges of delivering traditional h ospitalbased cardiac rehabilitation, such as cost and accessibility, alternative models have now been developed. For example, in high-income and middle-income countries, home and community-based cardiac rehabilitation programmes have been established. 72, 96, 123, 135 These programmes are as effective as traditional hospital-based cardiac rehabilitation at reducing CVD risk factors and mortality according to systematic literature reviews. 70, 136, 137 Unfortunately, owing to rigid approaches towards re imbursement for these models, such as lack of payment for health-care provider time in delivering cardiac rehabilitation sessions over the phone, on the internet, or at a community centre, their implementation has not been widespread. The UK, however, is a notable exception. 138 Another alternative model for cardiac rehabilitation implementation is provision within the primary healthcare setting, 139, 140 which is much more broadly available globally than specialty care. Integration of chronic and primary health care in low-resource settings has been successful, such as for diabetes and hypertension. 141 How ever, although such findings are promising, the time available to primary health-care providers to engage in preventive care is often limited. Allied health-care professionals, such as physiotherapists or occupational therapists, trained in the core elements of cardiac rehabili tation might, therefore, support cardiac re habilitation p rovision in this context.
Finally, internet-based, telephone-based, and mobile device-based delivery modalities are an increasingly active area of cardiac rehabilitation research. 136, 142 These programme models have advantages in terms of cost, time (they are less likely to conflict with work or family obligations, and no transportation is required), privacy (no group embarrassment), and in overcoming logistical barriers, such as infrastructure and human resource constraints. According to our own literature review, internetbased models incorporating, for example, a web-based recording system of vital signs such as heart rate or blood pressure, online tutorials and educational modules on all the core components of cardiac rehabilitation, online discussion groups with peers and cardiac rehabilitation professionals, or a combination of these approaches have only been tested in high-income countries to date. 136, 142 Owing to wide variation in internet-based interventions, a direct comparison between the effectiveness of internet-based and hospital-based cardiac rehabilitation programmes was not possible in a systematic review. 142 How ever, the authors reported that internet-based interventions have positive effects on health behaviour, as well as psychosocial and clinical outcomes (such as blood pressure, cholesterol levels, and hospital visits). 142 Cardiac rehabilitation delivered on mobile devices, such as monitored exercise training via smartphone appli cations, text messages, voice calls, or mobile-based questionnaires on health behaviour, are emerging in high-income countries. These strategies have shown promising results, including improvement in exercise capacity and risk factors (blood pressure, glycated haemoglobin level, and BMI). 136, 143 Although data on the effectiveness of cardiac rehabilitation delivered on a mobile device has yet to be reported from LMICs, one study is under way in Jordan. 143, 144 Given the penetrance of mobile technology in many LMICs, with rates of ownership as high as 45% in low-income countries and 76% in lower-middle-income countries, mobile-based strategies have great potential to increase delivery of cardiac rehabilitation. 145 In terms of interventions based on social media, the authors of a 2014 meta-analysis reported that such strategies for promoting healthy diet and exercise behaviours had no effect in the general population. 146 Whether this delivery approach will be effective in the area of cardiac rehabilitation remains to be determined.
Conclusions
Although the global burden of CVD and cardio vascular death are increasing, the global availability of cardiac rehabilitation is very low. In our review of the published literature and internet searches, only 38.8% of countries have cardiac rehabilitation programmes. The problem is most severe in LMICs, where only 23% of countries have cardiac rehabilitation programmes. Some m iddle-income countries have as few as one programme per 6 million inhabitants, yet LMICs have the greatest burden of CVD.
Cardiac rehabilitation use has increased in the USA and much of Western Europe, countries that have established, but diverse, health-care system delivery models.
We must now focus on tailoring these approaches for LMICs to improve cardiac rehabilitation participation. Novel delivery modalities for cardiac rehabilitation are very promising, particularly given the penetrance of mobile phones in LMICs. Cardiac rehabilitation is equally effective as more-invasive and expensive interventions for improving quality of life and clinical outcomes in low-risk patients. Therefore, as cardiology services are developed in LMICs, cardiac rehabilitation should be at the forefront of care.
Review criteria
MEDLINE, EMBASE, and Google Scholar were searched for relevant articles published between database inception and October 2013 using the following terms: "heart diseases", "heart failure", "angioplasty", "rehabilitation", "recovery of function", "physical therapy modalities", "secondary prevention", and "physical medicine". The authors' also used their personal collections of journal articles and references from key articles to write the Review. Internet search engines were queried with "cardiac rehabilitation" by country, and for services provided by hospitals within those countries.
